— Our Commitment

Experts for Orphan Drugs in Central & Eastern Europe

To deliver your unique medicine to each and every patient with rare disease by providing integral business solutions.

Learn more

— Our Mission

Experts for Orphan Drugs in Central & Eastern Europe

To serve each and every patient with rare disease by deploying our knowledge, experience and passion in enabling access to orphan drugs.

Learn more

— Our Team

Experts for Orphan Drugs in Central & Eastern Europe

International team of committed, knowledgeable, reliable and enthusiastic pharmaceutical professionals.

Learn more

Latest news

See all news

December 13, 2023

ExCEEd Orphan Announces Extension of an Exclusive Distribution Agreement with Mirum Pharmaceuticals for Marketing and Distribution of LIVMARLI™ (maralixibat) to Additional CEE Countries

ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o., …

November 16, 2023

ExCEEd Orphan announces extension of an exclusive Distribution Agreement with Advicenne for marketing and distribution of Sibnayal® in Estonia, Latvia and Lithuania

ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o., …

January 19, 2023

ExCEEd Orphan announces opening of its affiliate in Poland

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

January 11, 2023

ExCEEd Orphan announces extension of partnership with Amryt to exclusively distribute Lojuxta® in 17 countries of Central and Eastern Europe (CEE)

ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o., …

November 18, 2022

Neobiomics AB and ExCEEd Orphan s.r.o. announce an extended partnership for ProPrems® in Estonia, Latvia and Lithuania

Stockholm, Sweden, 17 Nov 2022 – Neobiomics AB and ExCEEd Orphan s.r.o. have …

November 1, 2022

ExCEEd Orphan announces new members of the team in several countries of the CEE region

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

August 1, 2022

Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases

Jerusalem, Israel and Prague, Czech Republic, August 1st, 2022. Rafa Laboratories LTD. (“Rafa”) …

July 15, 2022

ExCEEd Orphan announces new member of the EO Management team

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

Our Clients

These brands work with us to deliver you the best possible service.

Let’s work together

We provide comprehensive services tailored to your business needs, goals and strategies in the CEE region.

In depth knowledge of local markets

We possess in depth knowledge of our local markets and profound understanding of all processes related to market entry and commercialization of innovative medications.

Native knowledge of local languages

As local residents and native speakers we are able to communicate directly and effectively with all relevant stakeholders in our countries.

Profound contacts and partnerships

We have profound contacts and strategic partnerships with all relevant stakeholders and decision makers involved in bringing your unique and innovative medicine to each and every patient with rare diseases.

Proven and strong track record

We have proven and strong track record of more than 100 years of cumulative experience with setting up and developing orphan drug businesses across Central & Eastern Europe.

Get in touch

Our Team

We are competent and passionate rare disease experts with over 100 years of cumulative experience in launching multiple innovative medications in Central & Eastern Europe. We all provide comprehensive market entry services enabling timely access to innovative medications for patients living with rare diseases in our respective countries.

More about us